Designer Protein launches reformulated Designer Whey protein powders
LOS ANGELES — Designer Protein on Tuesday announced the launch of a reformulated line of Designer Whey protein powders.
"This refresh is the culmination of months spent understanding what is most important to our consumers," stated Grace Jeon, CEO Designer Protein. "Nutrition and wellness are important to keep fueled, but advice on easy integration of sustaining this balanced lifestyle is also important. As a result, we set out to not only deliver without mystery the product benefits our consumers told us were important — taste, health, quality ingredients, convenience and minimal calories — but also deliver on their request for dynamic advice on healthy, active living."
The Designer Whey Protein Powders contain 18 g of whey protein and are fortified with calcium, vitamin D and B vitamins.
Onglyza improves blood-sugar control in patients with high cardiovascular disease risk
PRINCETON, N.J. — A drug made by Bristol-Myers Squibb and AstraZeneca improved several measures of blood-sugar control in Type 2 diabetes patients at high risk of cardiovascular disease, according to results of a late-stage clinical trial announced Monday.
The drug makers announced results of a 1,681-patient phase-3 trial of Onglyza (saxagliptin), in which patients received 5-mg doses of the drug. Results of the 24-week trial showed improved blood-sugar control as measured by HbA1C, fasting plasma glucose and post-meal glucose compared with placebo. Results of the study were presented Monday at the 17th World Congress on Heart Disease in Toronto.
"The population of patients with Type 2 diabetes who are at increased risk for cardiovascular disease was highlighted in a recently issued position statement by the American Diabetes Association and the European Association for the Study of Diabetes," lead study investigator and AstraZeneca global medical affairs manager William Cook said.
The drug, combined with exercise and changes in diet, is already approved for various patients with Type 2 diabetes.
Randy Heiser joins McKesson as director of retail national accounts of Six Sigma
SAN FRANCISCO — Randy Heiser recently joined McKesson as director of retail national accounts of Six Sigma, DSN has learned.
Heiser comes to McKesson from Giant Eagle, where he was VP pharmacy and oversaw the day-to-day operation of more than 209 locations. Heiser started his retail pharmacy career in 1980 with Rite Aid, where he worked his way up to director of professional placement and director of pharmacy and therapeutic
Heiser graduated with a bachelor of science degree in pharmacy from the University of Pittsburgh in 1983, and went on to receive his MBA from the University of Pittsburgh in 1999.